Author:
Cui Xin-yu,Liu Tian-hua,Bai Ya-li,Zhang Meng-di,Li Guo-dong,Zhang Yu-ting,Yuan Yue-ying,Zhang Ya-wen,Yu Li-shuang,Han Li-na,Wu Yan
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res 2018;122:624–638.
2. Bajaj NS, Osborne MT, Gupta A, Tavakkoli A, Bravo PE, Vita T, et al. Coronary microvascular dysfunction and cardiovascular risk in obese patients. J Am Coll Cardiol 2018;72:707–717.
3. Camici PG, d’Amati G, Rimoldi O. Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol 2015;12:48–62.
4. Broyd CJ, Hernández-Pérez F, Segovia J, Echavarría-Pinto M, Quirós-Carretero A, Salas C, et al. Identification of capillary rarefaction using intracoronary wave intensity analysis with resultant prognostic implications for cardiac allograft patients. Eur Heart J 2018;39:1807–1814.
5. Zhang MD, Cui XY, Yuan YY, Zhang YT, Yu X, Wu Y. Mechanism of Shexiang Tongxin Dropping Pills in improving cardiac function in diabetic rat with myocardial infarction by promoting angiogensis. Tianjin J Tradit Chin Med (Chin) 2022;39:1043–1051.